Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Zepbound Outperforms CagriSema in Head to Head Phase III Obesity Trial CagriTirz (Cagrilintide + Tirz) >99% Purity Efficacy and Safety of Tirzepatide for Weight Management in Non Diabetic Obese Individuals: A Narrative Review Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link